Cargando…
First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy
OBJECTIVES: The authors present the first use of the novel positron emission tomography (PET) apoptosis tracer (18)F-labeled 2-(5-fluoro-pentyl)-2-methyl-malonic acid ((18)F-ML-10) for early-therapy response assessment of a newly diagnosed glioblastoma multiforme (GBM) patient. CASE REPORT: A 71-yea...
Autores principales: | Oborski, Matthew J, Laymon, Charles M, Lieberman, Frank S, Drappatz, Jan, Hamilton, Ronald L, Mountz, James M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967545/ https://www.ncbi.nlm.nih.gov/pubmed/24683522 http://dx.doi.org/10.1002/brb3.217 |
Ejemplares similares
-
[(18)F]ML-10 PET: Initial Experience in Glioblastoma Multiforme Therapy Response Assessment
por: Oborski, Matthew J., et al.
Publicado: (2016) -
Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme
por: Fazeny-Dörner, B, et al.
Publicado: (2003) -
The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme
por: Lai, Rose, et al.
Publicado: (2010) -
Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH–Wild-Type Glioblastoma
por: Albert, Nathalie L., et al.
Publicado: (2023) -
Infrared Thermography in Surgery of Newly Diagnosed Glioblastoma Multiforme: A Technical Case Report
por: Naydenov, Emanuil, et al.
Publicado: (2017)